Vesiculab’s Post

Investigating how conjugation chemistry influences targeted nanoparticles: in their latest work, Michael Zaleski, Jake Brenner at the University of Pennsylvania and collaborators demonstrated that the commonly used conjugation chemistries for antibody-targeted nanoparticles play a direct role in activating the complement cascade of plasma proteins. This complement activation significantly alters nanoparticle biodistribution, leading to up to a 140-fold increase in uptake by lung phagocytes, and causes various toxicities, including a 50% reduction in platelet count https://lnkd.in/eK-7X7zj Their findings underscore the critical importance of conjugation chemistry in advancing nanomedicine, emphasising that it is not without risk and must be carefully designed with consideration for opsonins like complement. An article co-authored by Liam Chase, Elizabeth Hood, Zhicheng Wang, Jia Nong, Carolann Espy, Marco Zamora, Jichuan Wu, Lianne Morrell, Vladimir Muzykantov and Jacob Myerson #Nanomedicines #targeteddelivery #drugdelivery #LNPs #conjugationchemistry #Vesiculab

  • DBCO-azide conjugation chemistry induces complement activation via protein aggregation on nanoparticle surfaces.

Thanks for the very interesting information or article.

To view or add a comment, sign in

Explore topics